Barclays’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Barclays’s Portfolio MOR Stock Details MOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14	Closed	-$1.03K	–	5591
2024 Q3	$1.03K	Buy	+14	New	+$259	﹤0.01%	5125
2023 Q2	–	Sell	-3	Closed	-$12	–	5209
2023 Q1	$12	Sell	3 -9	-75%	-$40	﹤0.01%	5032
2022 Q4	$43	Buy	+12	New	+$54	﹤0.01%	5218
2021 Q4	–	Sell	-40	Closed	–	–	4832
2021 Q3	$0	Buy	+40	New	+$579	﹤0.01%	5078
2021 Q2	–	Sell	-166	Closed	-$4K	–	5124
2021 Q1	$4K	Buy	+166	New	+$4.43K	﹤0.01%	4510

Barclays's MOR Position: Q4 2024 in Review

Barclays sold out of MorphoSys AG American Depositary Shares (MOR) in Q4 2024, closing a stake of 14 shares — an estimated $1.03K sold.

Barclays first reported a position in MOR in Q1 2021 and held it in 5 quarters. The position peaked at $4K in Q1 2021. 0 funds tracked by Wall St. Rank hold MOR as of Q4 2024.

Barclays reported no remaining MorphoSys AG American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Barclays sold 14 MorphoSys AG American Depositary Shares shares in Q4 2024, an estimated $1.03K.
Barclays first reported a position in MorphoSys AG American Depositary Shares in Q1 2021 and held it in 5 quarters.
Barclays's MorphoSys AG American Depositary Shares position peaked at $4K in Q1 2021.
0 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q4 2024.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.